Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13795066

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

Author
DONOHUE, James F1 ; VAN NOORD, Jan A2 ; BATEMAN, Eric D3 ; LANGLEY, Stephen J4 ; LEE, Angela5 ; WITEK, Theodore J6 ; KESTEN, Steven6 ; TOWSE, Lesley5
[1] Division of Pulmonary Medicine, University of North Carolina, Chapel Hill, NC, United States
[2] Department of Respiratory Diseases, Atrium Medical Center, Heerlen, Netherlands
[3] Respiratory Clinic, Groot Schuur Hospital, University of Cape Town, Cape Town, South Africa
[4] Clinical Trials Department, North West Lung Research Center, Wythenshawe Hospital, Manchester, United Kingdom
[5] Boehringer Ingelheim Ltd., Bracknell, Berkshire, United Kingdom
[6] Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, United States
Source

Chest. 2002, Vol 122, Num 1, pp 47-55 ; ref : 27 ref

CODEN
CHETBF
ISSN
0012-3692
Scientific domain
Anesthesia, intensive care; Cardiology, blood circulation, phlebology; Pneumology
Publisher
American College of Chest Physicians, Northbrook, IL
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Bromure de tiotropium Bronchodilatateur Bronchopneumopathie obstructive Chimiothérapie Chronique Etude comparative Etude longitudinale Fonction respiratoire Homme Pronostic Qualité vie Salmétérol Stimulant β-adrénergique Traitement VEMS Appareil respiratoire pathologie Bronche pathologie Poumon pathologie
Keyword (en)
Tiotropium bromide Bronchodilator Obstructive pulmonary disease Chemotherapy Chronic Comparative study Follow up study Lung function Human Prognosis Quality of life Salmeterol β-Adrenergic receptor agonist Treatment Maximal expiratory volume per second Respiratory disease Bronchus disease Lung disease
Keyword (es)
Bromuro de tiotropio Broncodilatador Broncopneumopatía obstructiva Quimioterapia Crónico Estudio comparativo Estudio longitudinal Función respiratoria Hombre Pronóstico Calidad vida Salmeterol Estimulante β-adrenérgico Tratamiento Volumen expiratorio máximo por segundo Aparato respiratorio patología Bronquio patología Pulmón patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02D Respiratory system

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
13795066

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web